Department of Endocrinology Diabetology and Metabolic Diseases, PCIM Laboratory, FMPM, Cadi Ayyad University, CHU Mohamed VI Marrakech, Morocco.
World Journal of Advanced Research and Reviews, 2023, 18(02), 462–464
Article DOI: 10.30574/wjarr.2023.18.2.0848
DOI url: https://doi.org/10.30574/wjarr.2023.18.2.0848
Received on 31 March 2023; revised on 07 May 2023; accepted on 10 May 2023
Di George syndrome or (the 22q11.2 deletion syndrome) is due to a chromosomal abnormality namely a genetic abnormality caused by a microdeletion of chromosome 22. The main manifestations are cardiac congenital malformations, thymic hypoplasia, and hypoparathyroidism with hypocalcemia, psychomotor retardation, craniofacial dysmorphies and sometimes immunodeficiency. The diagnosis can be made antenatally, during fetopathological examination or after birth. We report the case of a 49-year-old female patient who was initially followed for iatrogenic hypoparathyroidism under Levothyrox replacement therapy and whose evolution was marked by the discovery of a Di George syndrome during follow-up.
Di George syndrome; Microdeletion; Hypocalcemia; Hypoparathyroidism
Get Your e Certificate of Publication using below link
Preview Article PDF
HASSAN ADEN. N, CAMARA. M, RAFI. S, El MGHARI. G and El ANSARI. N. Di George syndrome revealed by hypocalcemia: A case report. World Journal of Advanced Research and Reviews, 2023, 18(02), 462–464. Article DOI: https://doi.org/10.30574/wjarr.2023.18.2.0848
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0